NeoGen announced strategic corporate moves, including a significant investment and partnership to create enzyme-based products, while the market awaited signals from the FED regarding interest rates and inflation.
2 reports, 1 independent
Updated Aug 14
Gone quiet
- Reports
- 2
- Developments
- 4
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeoGen announced strategic corporate moves, including a significant investment and partnership to create enzyme-based products, while the market awaited signals from the FED regarding interest rates and inflation.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- NeoGen sold its global genomics business unit to Zoetis Inc.Sub-event
- NeoGen divested its cleaners and disinfectants business and used the proceeds from the sale to repay debt.Sub-event
NeoGen disclosed a significant investment and partnership to create enzyme-based products, amid market hopes for FED rate cuts due to easing inflation.1 source
Market environment for NeoGen questioned by industry figures and analysts.1 source
Keep exploring
The entities involved
-
NeoGen
international food safety company
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStoryWhy Neogen (NEOG) Stock Is Up Today Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 5.2% in the afternoon session after an investment group led by Clarkston Capital Partners disclosed a s
- StockStoryThe 5 Most Interesting Analyst Questions From Neogen’s Q2 Earnings Call Neogen’s second quarter saw a negative market reaction following results that reflected ongoing challenges in the company’s pri